Ardian recently announced it has entered exclusive talks with Equistone Partners Europe to take ownership of Unither Pharmaceuticals in a transaction valued at around €675m. Alice Tchernookova reports
If Ardian’s €675m deal for Unither Pharmaceuticals is brought to completion as planned in Q1 2017, the new capital structure will see the GP take a majority share in the company. Company management,...
Venture capital firms originally invested in the company in 2011 and 2014 respectively
Fund manager Quaestus exits its stake in the Croatian business after an eight-year holding period
Proposed deal for the aluminium profiles manufacturer comes just two years after Advent's acquisition
Deal marks first investment by small-cap buyout fund Crescendo, which held a €42m first close this year